Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-881-7 | CAS number: 10411-92-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation/corrosion: not irritating (Read-across, OECD 439, GLP, K, rel. 1).
Eye irritation: not irritating (Read-across, OECD 405, K, rel.2)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2012-09-04 to 2012-10-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 439 and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 22 July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- 2008
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK GLP Compliance Monitoring Programme (inspected on 10 July 2012)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- Several in vivo studies were presumably conducted on the substance. However discordant results were reported, bringing doubts on the identity, purity and composition of the tested substances. As it was not possible to obtain certificates of analysis of the tested batches, it was deemed necessary to conduct a new in vitro study on the substance.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN™ Reconstructed Human Epidermis Model Kit
- Supplier: SkinEthic Laboratories, Lyon, France
- Tissue batch number(s): 12-EKIN-037
- Production date: not reported
- Shipping date: not reported
- Delivery date: 09 October 2012
- Date of initiation of testing: 09 October 2012 (Pre-incubation); 10 October 2012 (main test)
- Expiry date: 15 October 2012
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature, 15 minutes
- Temperature of post-treatment incubation (if applicable): 37°C, 42 hours
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: At the end of the exposure period, each tissue was removed from the well using forceps and rinsed using a wash bottle containing DPBS with Ca++ and Mg++. Rinsing was achieved by filling and emptying each tissue insert for approximately 40 seconds using a constant soft stream of DPBS to gently remove any residual test item. The rinsed tissues were transferred to the second column of 3 wells containing 2 ml of maintenance medium in each well.
- Observable damage in the tissue due to washing: none observed
- Modifications to validated SOP: none
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 hours
- Spectrophotometer: Anthos 2001 microplate reader
- Wavelength: 540 nm
- Filter: without a reference filter
- Linear OD range of spectrophotometer: not reported
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: 22.2 ± 0.3 (CV = 1.2 %) (≥ 19.5)
- Barrier function: IC50 = 2.1 mg/ml (IC50 ≥ 1.5 mg/ml)
- Morphology: Well-differenciated epidermis consisting of a basal layer, several spinous and granular layers and a thick stratum corneum.
- Contamination:
On blood : absence of HIV1 and 2 antibodies (Architect Abbott); absence of hepatitis C antibodies (Architect Abbott); absence of hepatitis B antigen HBs (Architect Abbott).
On epidermal cells: absence of bacteria, fungus and mycoplasma.
- Reproducibility: All values for the control groups were within the ranges obtained by the testing laboratory in the preceding 120 studies. This was taken to show the correct functioning of the test system.
NUMBER OF REPLICATE TISSUES: Triplicate tissues for test item, negative and positive controls
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
Not applicable, the test item did not directly reduce MTT.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- Relative mean tissue viability is ≤50%: Irritant
- Relative mean tissue viability is >50%: Non-Irritant (CLP) - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 µL
- Concentration (if solution): as supplied.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 10 µL
- Concentration (if solution): as supplied
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 10 µL
- Concentration (if solution): 5% (w/v) - Duration of treatment / exposure:
- 15 minutes
- Duration of post-treatment incubation (if applicable):
- 42 hours
- Number of replicates:
- 3
- Vehicle:
- unchanged (no vehicle)
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 62.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 5.8%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: none
- Direct-MTT reduction: no
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: yes
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the mean OD540 for the negative control treated tissues was 0.740 and the standard deviation value of the viability was 6.62%. The negative control
acceptance criteria were therefore satisfied.
- Acceptance criteria met for positive control: Yes; the relative mean tissue viability for the positive control treated tissues was 5.8% relative to the negative control treated tissues and the standard devi
ation value of the viability was 0.7%. The positive control acceptance criteria were therefore satisfied.
- Acceptance criteria met for variability between replicate measurements: The standard deviation calculated from individual tissue viabilities of the three identically test item treated tissues was 6.9%. The test acceptance criterion was therefore satisfied.
- Range of historical values if different from the ones specified in the test guideline: All values for the control groups were within the ranges obtained by the testing laboratory in the preceding 120 studies. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The test material is not classified as irritating to skin in this in vitro assay according to the criteria of the Regulation (EC) No (1272/2008 (CLP).
- Executive summary:
The purpose of this test was to evaluate the skin irritation potential of the test material using the EPISKINTM reconstructed human epidermis model after a treatment period of 15 minutes followed by a post-exposure incubation period of 42 hours. The principle of the assay is based on the measurement of cytotoxicity in reconstructed human epidermal cultures following topical exposure to the test item by means of the colorimetric MTT (3‑[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) reduction assay. Cell viability is measured by enzymatic reduction of the yellow MTT tetrazolium salt to a blue formazan salt (within the mitochondria of viable cells) in the test item treated tissues relative to the negative controls.
This test was designed to be compatible with the OECD Guideline No. 439 and was performed in compliance with GLP.
Triplicate tissues were treated with the test item for an exposure period of 15 minutes. At the end of the exposure period each tissue was rinsed before incubating for 42 hours. At the end of the post‑exposure incubation period each tissue was taken for MTT-loading. After MTT loading a total biopsy of each epidermis was made and placed into micro tubes containing acidified isopropanol for extraction of formazan crystals out of the MTT‑loaded tissues.
At the end of the formazan extraction period each tube was mixed thoroughly and duplicate 200 µl samples were transferred to the appropriate wells of a pre‑labelled 96‑well plate. The optical density was measured at 540 nm.
The relative mean viability of the test item treated tissues was 62.6 ± 6.9 %, after the 15‑minute exposure period.
The quality criteria required for acceptance of results in the test were satisfied.
The test material was considered to be non-irritant according to the criteria of the Regulation (EC) No 1272/2008 (CLP).
This study is considered as acceptable and satisfies the requirement for skin irritation endpoint.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included in Iuclid Section 13.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
This read-across is based on the hypothesis that the source and target substances have similar physico-chemical and toxicological properties because of their structural similarity.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
The target and source substances both contain the same two isomers, in a different ratio: the source substance is a multi-constituent, while the target substance is defined as a mono-constituent, the second constituent being an impurity.
3. ANALOGUE APPROACH JUSTIFICATION
Based on structural similarity, and on the concentration of cis-isomers (above the generic concentration limits for classification of mixture set by the CLP Regulation) in the test performed on the source substance, it is considered appropriate and scientifically justified to read-across the data from the source to the target substance.
The study design (OECD 439, GLP) is adequate and reliable for the purpose of the prediction based on read-across. The test material used represents the source substance as described in the hypothesis in terms of purity and impurities. The results of the studies are adequate for the purpose of classification and labelling.
Therefore, based on the considerations above, it can be concluded that the result of the In vitro skin irritation test conducted with the source substance is highly likely to predict the properties of the target substance and is considered as adequate to fulfil the information requirement of Annex VII, 8.1.
4. DATA MATRIX
Cf. Iuclid Section 13. - Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across: supporting information
- Vehicle:
- unchanged (no vehicle)
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 62.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 5.8%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: none
- Direct-MTT reduction: no
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: yes
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the mean OD540 for the negative control treated tissues was 0.740 and the standard deviation value of the viability was 6.62%. The negative control
acceptance criteria were therefore satisfied.
- Acceptance criteria met for positive control: Yes; the relative mean tissue viability for the positive control treated tissues was 5.8% relative to the negative control treated tissues and the standard devi
ation value of the viability was 0.7%. The positive control acceptance criteria were therefore satisfied.
- Acceptance criteria met for variability between replicate measurements: The standard deviation calculated from individual tissue viabilities of the three identically test item treated tissues was 6.9%. The test acceptance criterion was therefore satisfied.
- Range of historical values if different from the ones specified in the test guideline: All values for the control groups were within the ranges obtained by the testing laboratory in the preceding 120 studies. - Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- The source substance is not classified as irritating to skin in this in vitro assay according to the criteria of the Regulation (EC) No (1272/2008 (CLP). The same conclusion applies to the target substance.
- Executive summary:
The purpose of this test was to evaluate the skin irritation potential of the source substance using the EPISKINTM reconstructed human epidermis model after a treatment period of 15 minutes followed by a post-exposure incubation period of 42 hours. The principle of the assay is based on the measurement of cytotoxicity in reconstructed human epidermal cultures following topical exposure to the test item by means of the colorimetric MTT (3‑[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) reduction assay. Cell viability is measured by enzymatic reduction of the yellow MTT tetrazolium salt to a blue formazan salt (within the mitochondria of viable cells) in the test item treated tissues relative to the negative controls.
This test was designed to be compatible with the OECD Guideline No. 439 and was performed in compliance with GLP.
Triplicate tissues were treated with the source substance for an exposure period of 15 minutes. At the end of the exposure period each tissue was rinsed before incubating for 42 hours. At the end of the post‑exposure incubation period each tissue was taken for MTT-loading. After MTT loading a total biopsy of each epidermis was made and placed into micro tubes containing acidified isopropanol for extraction of formazan crystals out of the MTT‑loaded tissues.
At the end of the formazan extraction period each tube was mixed thoroughly and duplicate 200 µl samples were transferred to the appropriate wells of a pre‑labelled 96‑well plate. The optical density was measured at 540 nm.
The relative mean viability of the source substance treated tissues was 62.6 ± 6.9 %, after the 15‑minute exposure period.
The quality criteria required for acceptance of results in the test were satisfied.
The source substance was considered to be non-irritant according to the criteria of the Regulation (EC) No 1272/2008 (CLP).
The same conclusion applies to the target substance [Read-across justification is attached to Iuclid section 13].
This study is considered as acceptable and satisfies the requirement for skin irritation endpoint.
Referenceopen allclose all
Table 7.3.1/1: Mean OD540 Values and Percentage Viabilities for the Negative Control Item, Positive Control Item and Test Item
Item |
OD540 of tissues |
Mean OD540 of triplicate tissues |
± SD of OD540 |
Relative individual tissue viability (%) |
Relative mean viability (%) |
± SD of Relative mean viability (%) |
Negative Control Item |
0.684 |
0.740 |
0.049 |
92.4 |
100* |
6.6 |
0.762 |
103.0 |
|||||
0.773 |
104.5 |
|||||
Positive Control Item |
0.044 |
0.043 |
0.005 |
5.9 |
5.8 |
0.7 |
0.038 |
5.1 |
|||||
0.048 |
6.5 |
|||||
Test Item |
0.437 |
0.463 |
0.059 |
59.1 |
62.6 |
6.9 |
0.431 |
58.2 |
|||||
0.522 |
70.5 |
SD= Standard deviation
*= The mean viability of the negative control tissues is set at 100%
Table 7.3.1/1: Mean OD540 Values and Percentage Viabilities for the Negative Control Item, Positive Control Item and Test Item
Item |
OD540 of tissues |
Mean OD540 of triplicate tissues |
± SD of OD540 |
Relative individual tissue viability (%) |
Relative mean viability (%) |
± SD of Relative mean viability (%) |
Negative Control Item |
0.684 |
0.740 |
0.049 |
92.4 |
100* |
6.6 |
0.762 |
103.0 |
|||||
0.773 |
104.5 |
|||||
Positive Control Item |
0.044 |
0.043 |
0.005 |
5.9 |
5.8 |
0.7 |
0.038 |
5.1 |
|||||
0.048 |
6.5 |
|||||
Test Item |
0.437 |
0.463 |
0.059 |
59.1 |
62.6 |
6.9 |
0.431 |
58.2 |
|||||
0.522 |
70.5 |
SD= Standard deviation
*= The mean viability of the negative control tissues is set at 100%
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 1982-01-14 to 1982-01-26
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Comparable to guideline study with acceptable restrictions: the study is non-GLP.
- Qualifier:
- according to guideline
- Guideline:
- other: USA IRLG Testing Standards and Guidelines Work Group (January 1981)
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: H. Fortkamp, 4540 Lengerich.
- Age at study initiation: 11-17 weeks
- Weight at study initiation: 2.20-2.63 kg bw
- Housing: individually, in steel greed floor cages over trays containing softwood sawdust bedding.
- Diet: ad libitum (Ssniff K Alleindiät für Kanichen, Ssniff Versuchstier-GmbH, 4770 Soest/Westfalen). Not contaminated.
- Water: main water ad libitum. Not contaminated.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23
- Humidity (%): 40-70
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- unchanged (no vehicle)
- Controls:
- other: right eye served as control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL - Duration of treatment / exposure:
- Eye were not rinsed after instillation
- Observation period (in vivo):
- Examination 1, 24, 48, 72 hours, and then 4 and 7 days after instillation
- Number of animals or in vitro replicates:
- 6 females
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): no done
SCORING SYSTEM: Draize scale
TOOL USED TO ASSESS SCORE: no data
Other: initial pain reaction caused by the test article was made using a 6 point scale. - Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.17
- Max. score:
- 3
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- other: discharge
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 3
- Irritant / corrosive response data:
- Practically no initial pain was seen in any animal on instillation. One hour after dosing moderate chemosis (grade 2) associated with moderate reddening (grade 2) were observed in 2/6 animals. The remaining 4 animals all showed slight chemosis (grade 1) and slight reddening (grade 1). The day after dosing one animal still showed slight chemosis associated with moderate reddening an on this occasion diffuse areas of corneal opacity and a slight ocular discharge were also noted. One further animal showed slight reddening only whilst the eyes of the remaining 4 animals appeared normal. Two days after treatment the eyes of all animals appeared normal.
- Other effects:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, the test material is not classified as irritating to eyes according to the criteria of the Regulation (EC) No 1272/2008 (CLP) and of the GHS
- Executive summary:
In an eye irritation study performed similarly to the OECD guideline No. 405, 0.1 mL of undiluted test material was instilled into the left eye of 6 female New Zealand White Rabbit. The eyes were not rinsed after the instillation of the test item. The right eye of each rabbit served as control. Animals were observed at 1, 24, 48 and 72 hours, and the 4 and 7 days after dosing. The reactions in the conjunctiva (redness, chemosis and discharge), the iris and the cornea (opacity and area involved) were scored according to the Draize scale.
Practically no initial pain was seen in any animal on instillation. One hour after dosing moderate chemosis (grade 2) associated with moderate reddening (grade 2) were observed in 2/6 animals. The remaining 4 animals all showed slight chemosis (grade 1) and slight reddening (grade 1). The day after dosing one animal still showed slight chemosis associated with moderate reddening an on this occasion diffuse areas of corneal opacity and a slight ocular discharge were also noted. One further animal showed slight reddening only whilst the eyes of the remaining 4 animals appeared normal. 48 hours after treatment the eyes of all animals appeared normal.
The calculated mean score for each individual lesion for all 6 animals within 3 scoring times (24, 48 and 72 hrs) were as follows: 0.17 for redness, 0.04 for chemosis; 0.08 for cornea opacity; 0.04 for area of cornea involved and 0.00 for discharge, iris and lesions.
Under the test conditions, the test material is not classified as irritating to eyes according to the criteria of the Regulation (EC) No 1272/2008 (CLP) and of the GHS.
This study is considered as acceptable and satisfies the requirement for eye irritation endpoint.
- Endpoint:
- eye irritation: in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included in Iuclid Section 13.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
This read-across is based on the hypothesis that the source and target substances have similar physico-chemical and toxicological properties because of their structural similarity.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
The target and source substances both contain the same two isomers, in a different ratio: the source substance is a multi-constituent, while the target substance is defined as a mono-constituent, the second constituent being an impurity.
3. ANALOGUE APPROACH JUSTIFICATION
Based on structural similarity, and on the concentration of cis-isomers (above the generic concentration limits for classification of mixture set by the CLP Regulation) in the test performed on the source substance, it is considered appropriate and scientifically justified to read-across the data from the source to the target substance.
Even if not performed under GLP, the study design (OECD 405) is sufficiently adequate and reliable for the purpose of the prediction based on read-across. The test material used represents the source substance as described in the hypothesis in terms of purity and impurities. The results of the studies are adequate for the purpose of classification and labelling.
Therefore, based on the considerations above, it can be concluded that the result of the In vivo eye irritation test conducted with the source substance is highly likely to predict the properties of the target substance and is considered as adequate to fulfil the information requirement of Annex VII, 8.2.
4. DATA MATRIX
Cf. Iuclid Section 13. - Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across: supporting information
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.17
- Max. score:
- 3
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 hrs
- Irritation parameter:
- other: discharge
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 3
- Irritant / corrosive response data:
- Practically no initial pain was seen in any animal on instillation. One hour after dosing moderate chemosis (grade 2) associated with moderate reddening (grade 2) were observed in 2/6 animals. The remaining 4 animals all showed slight chemosis (grade 1) and slight reddening (grade 1). The day after dosing one animal still showed slight chemosis associated with moderate reddening an on this occasion diffuse areas of corneal opacity and a slight ocular discharge were also noted. One further animal showed slight reddening only whilst the eyes of the remaining 4 animals appeared normal. Two days after treatment the eyes of all animals appeared normal.
- Other effects:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, the source substance is not classified as irritating to eyes according to the criteria of the Regulation (EC) No 1272/2008 (CLP) and of the GHS. The same conclusion applies to the target substance.
- Executive summary:
In an eye irritation study performed similarly to the OECD guideline No. 405, 0.1 mL of undiluted source substance was instilled into the left eye of 6 female New Zealand White Rabbit. The eyes were not rinsed after the instillation of the source substance. The right eye of each rabbit served as control. Animals were observed at 1, 24, 48 and 72 hours, and the 4 and 7 days after dosing. The reactions in the conjunctiva (redness, chemosis and discharge), the iris and the cornea (opacity and area involved) were scored according to the Draize scale.
Practically no initial pain was seen in any animal on instillation. One hour after dosing moderate chemosis (grade 2) associated with moderate reddening (grade 2) were observed in 2/6 animals. The remaining 4 animals all showed slight chemosis (grade 1) and slight reddening (grade 1). The day after dosing one animal still showed slight chemosis associated with moderate reddening an on this occasion diffuse areas of corneal opacity and a slight ocular discharge were also noted. One further animal showed slight reddening only whilst the eyes of the remaining 4 animals appeared normal. 48 hours after treatment the eyes of all animals appeared normal.
The calculated mean score for each individual lesion for all 6 animals within 3 scoring times (24, 48 and 72 hrs) were as follows: 0.17 for redness, 0.04 for chemosis; 0.08 for cornea opacity; 0.04 for area of cornea involved and 0.00 for discharge, iris and lesions.
Under the test conditions, the test material is not classified as irritating to eyes according to the criteria of the Regulation (EC) No 1272/2008 (CLP) and of the GHS. The same conclusion applies to the source substance. Read-across justification is attached to Iuclid section 13.
This study is considered as acceptable and satisfies the requirement for eye irritation endpoint.
Referenceopen allclose all
Table 7.3.2/1: Mean irritant/corrosive response data for all animals at each observation time up to removal from the test
Score at time point / Reversibility |
Cornea |
Iris (/2) |
Conjunctivae |
|||
Opacity (/4) |
Area (/4) |
Redness (/3) |
Chemosis (/4) |
Discharge (/3) |
||
1 h |
0.00 |
0.00 |
0.00 |
1.33 |
1.33 |
0.00 |
24 h |
0.13 |
0.25 |
0.00 |
0.50 |
0.13 |
0.00 |
48 h |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
72 h |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Average 24h, 48h, 72h |
0.04 |
0.08 |
0.00 |
0.17 |
0.04 |
0.00 |
Reversibility*) |
c. |
c. |
- |
c. |
c. |
- |
Average time (unit) for reversion |
48h |
48h |
- |
48 h |
48 h |
- |
*) Reversibility: c. = completely reversible; n.c. = not completely reversible; n. = not reversible
Table 7.3.2/1: Mean irritant/corrosive response data for all animals at each observation time up to removal from the test
Score at time point / Reversibility |
Cornea |
Iris (/2) |
Conjunctivae |
|||
Opacity (/4) |
Area (/4) |
Redness (/3) |
Chemosis (/4) |
Discharge (/3) |
||
1 h |
0.00 |
0.00 |
0.00 |
1.33 |
1.33 |
0.00 |
24 h |
0.13 |
0.25 |
0.00 |
0.50 |
0.13 |
0.00 |
48 h |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
72 h |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Average 24h, 48h, 72h |
0.04 |
0.08 |
0.00 |
0.17 |
0.04 |
0.00 |
Reversibility*) |
c. |
c. |
- |
c. |
c. |
- |
Average time (unit) for reversion |
48h |
48h |
- |
48 h |
48 h |
- |
*) Reversibility: c. = completely reversible; n.c. = not completely reversible; n. = not reversible
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation:
No study was available on cis-4-tert-butylcyclohexyl acetate, therefore an analogue approach using the supporting substance, 4-tert-butylcyclohexyl acetate, was followed to conclude on the skin irritation potential of cis-4-tert-butylcyclohexyl acetate (cf. Section 11 for read-across justification). The key study (Envigo, 2012, rel. 1) was conducted according to the OECD Guideline No. 439 and was performed in compliance with GLP. The quality criteria required for acceptance of results in the test were satisfied. The relative mean viability of the test item treated tissues was 64.7 ± 7.6 %, after the 15 minute exposure period. With a tissue viability > 50%, 4 -tert-butylcyclohexyl acetate was considered to be non-irritant to skin. The EPISKIN in vitro model is a stand-alone replacement test for in vivo skin irritation testing and allows identifying non-classified chemicals.
The supporting substance and the registered substance being only different in their ratio of the isomers, the conclusion on 4 -tert-butylcyclohexyl acetate was extended to cis-4 -tert-butylcyclohexyl acetate.
Eye irritation:
No study was available on cis-4-tert-butylcyclohexyl acetate, therefore an analogue approach using the supporting substance, 4-tert-butylcyclohexyl acetate, was followed to conclude on the skin irritation potential of cis-4-tert-butylcyclohexyl acetate (cf. Section 11 for read-across justification).
A key study was identified (Hazleton, 1982, rel. 2). In this eye irritation study performed similarly to the OECD guideline No. 405, 0.1 mL of undiluted 4 -tert-butylcyclohexyl acetate was instilled into the left eye of 6 rabbits. The eyes were not rinsed after the instillation of the test item. The right eye of each rabbit served as control. Practically no initial pain was seen in any animal on instillation. One hour after dosing moderate chemosis (grade 2) associated with moderate reddening (grade 2) were observed in 2/6 animals. The remaining 4 animals all showed slight chemosis (grade 1) and slight reddening (grade 1). The day after dosing one animal still showed slight chemosis associated with moderate reddening an on this occasion diffuse areas of corneal opacity and a slight ocular discharge were also noted. One further animal showed slight reddening only whilst the eyes of the remaining 4 animals appeared normal. 48 hours after treatment the eyes of all animals appeared normal. The calculated mean score for each individual lesion for all 6 animals within 3 scoring times (24, 48 and 72 hrs) were as follows: 0.17 for redness, 0.04 for chemosis; 0.08 for cornea opacity; 0.04 for area of cornea involved and 0.00 for discharge, iris and lesions. Under the test conditions, 4 -tert-butylcyclohexyl acetate is not classified as irritating to eyes.
The supporting substance and the registered substance being only different in their ratio of the isomers, the conclusion on 4 -tert-butylcyclohexyl acetate was extended to cis-4 -tert-butylcyclohexyl acetate.
Justification for classification or non-classification
Harmonised classification:
The substance has no harmonised classification according to the Regulation (EC) No. 1272/2008 (CLP).
Self classification:
Based on the available information no additional self-classification is proposed regarding both skin and eye irritation according to the CLP and to the GHS.
No data was available regarding respiratory irritation, however the substance not being classified for skin and eye irritation, no classification is expected for respiratory irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.